Case Studies

Defending an Injunction

Our client is a generic pharmaceutical company. It wanted to launch a generic alternative of a formulation of a drug that was patented, in the UK and elsewhere. Its objectives were to do whatever was necessary to ensure that, no interim injunction was awarded against it following the extensive marketing that it had done prior to launch and, if sued, it would be in the best position possible to defend the action. Read more…

Enforcing IP Rights

Our client was a major R&D based chemicals manufacturer concerned about the activities of a well-funded UK-based individual who had obtained marketing authorisation for various companies controlled by him, to sell under their own names a parallel imported patented pesticide product manufactured by our client. The active ingredient concerned was covered by our client’s UK patent. Given the price at which the products were being sold, our client suspected that they were in fact counterfeit and that the infringer was involved with the supply of other counterfeit goods infringing its patents. Read more…

Injuncting Multiple Infringers

Our client, BASF, is the world’s largest chemical company. BASF discovered that a number of Chinese manufacturers were planning to offer for sale at the world’s largest agrochemicals conference goods that infringed BASF patents. We were tasked with stopping these sales and sending a warning out to other would-be infringers that BASF aggressively protected its rights. Read more…

Switching from Product Manufacture to a Licensing Business

Our client had an extensive R&D and Patents department and had newly developed ground-breaking technology for needleless injection but little experience of licensing out its inventions. We were tasked with finding a way for our client to maximise its income from the device by establishing a series of exclusive licenses for different therapeutic indications. In this way, the device was used in many more applications than our client could practically manufacture and sell. Read more…

Maximising Licence Revenues

Our client was a small company that had been spun out of a university pharmacy department. Its business depended upon a class of patented chemicals, which had applications in a number of fields beyond pharmaceuticals. Unfortunately, our client was locked into an unfavourable existing agreement. We identified lawful means for our client to withdraw from the existing agreement and to maximise its revenues with a series of new licensing and collaboration agreements. Read more…

Revoking a Patent

Our client was a chemicals manufacturer with a successful process for manufacturing a pharmaceutical intermediate that was the basis of a major blockbuster product. A number of generics manufacturers were obtaining marketing authorisations based upon using our client’s intermediate, but the particular form of the API was subject to a third party patent making a legal challenge to its use in generics manufacture almost inevitable. We advised our client that its best course of action would be to bring patent revocation proceedings in order to ‘clear the way’ and we successfully brought those proceedings, revoking the patent in an expedited trial. Read more…